Cleopatra Hospital is trading 3.23% down at $15.29, with no clear cause established for the September 25, 2026 session decline.

  • No company announcement dated September 25 or September 27 clearly explains the move, and no matching market-wide catalyst is established in the supplied context.
  • September 6 results showed first-half net profit after tax fell 34.4% year over year despite revenue growth of 27.4%; this is background, not an established cause.